Cardiovascular Journal of Africa • Volume 31, No 4 August 2020
S41
AFRICA
Actions to be taken are:
• community sensitisation on a healthy diet and PA
• early detection and appropriate management of CVD
• preventive treatment for stroke and myocardial infarction
(aspirin, statins)
• preventive treatment for rheumatic fever (penicillin).
17
This publication was reviewed by the PASCAR governing council and
approved by the president of the Tanzania Cardiac Society.
References
1. Mohamed AA, Fourie JM, Scholtz W,
et al.
Sudan Country Report: PASCAR
and WHF Cardiovascular Diseases Scorecard project.
Cardiovasc J Afr
2019;
30
: 305–310.
2. Dzudie A, Fourie JM, Scholtz W,
et al.
Cameroon Country Report: PASCAR
and WHF Cardiovascular Diseases Scorecard project.
Cardiovasc J Afr
2020;
31
(2): 103–110.
3. World Bank [Online] 2017.
https://data.worldbank.org/.4. World Health Organization. CVD World Monitor. [Online] 2012. http://
cvdworldmonitor.org/targets/premature-mortality-due-to-cvd/.5. Institute for Health Metrics and Evaluation (IHME). GHDx. Global Health
Data Exchange. [Online] 2017.
http://ghdx.healthdata.org/gbd-results-tool.6. World Health Organization. The World Health Organization framework
convention on tobacco control (FCTC). [Online] 2018. http://untobaccocontrol.
org/impldb/United_Republic_of_Tanzania_2018_report.pdf.
7. Shayo FK. Co-occurrence of risk factors for non-communicable diseases
among in-school adolescents in Tanzania: an example of a low-income
setting of sub-Saharan Africa for adolescence health policy actions.
BMC
Publ Health
2019;
19
: 972.
8. World Health Organization. Global report on mortality attributable to tobacco.
Geneva, Switzerland: World Health Organization, 2012.
9. The Global Health Observatory (GHO). WHO. [Online] 2020. https://www.
who.int/data/gho/.
10. Guthold R, Stevens GARiley LM,
et al.
Global trends in insufficient physical
activity among adolescents: a pooled analysis of 298 population-based
surveys with 1·6 million participants.
Lancet Child Adolesc Health
2020;
4
(1): 23–35.
11. International Diabetes Federation.
IDF Diabetes Atlas
, 9th edn. [Online]
2019.
http://www.diabetesatlas.org/en/resources/.html.12. World Health Organization. WHO CVD-risk management package for low-
and medium-resource settings. Geneva: WHO, 2002.
13. Lloyd-Jones DM, Huffman MD, Karmali KN. Estimating longitudinal risks
and benefits from cardiovascular preventive therapies among medicare
patients.
J Am Coll Cardiol
2017;
69
(12): 1617–1636.
14. Ministry of Health, Community Development, Gender, Elderly and Children.
Standard Treatment Guidelines and the National Essential Medicines List
Tanzania Mainland. Dar es Salaam: The United Republic of Tanzania,
March 2017.
15. Mayige M, Kagaruki G, Ramaiya K, Swai A. Non communicable diseases in
Tanzania: a call for urgent action.
Tanzania J Health Res
2012;
14
(2): 1–12.
16. Edwards R, Unwin N, Mugusi F,
et al.
Hypertension prevalence and care in an
urban and rural area of Tanzania.
J Hypertens
2000;
18
(2): 145–152.
17. Ministry of Health, Community Development, Gender, Elderly and
Children. Strategic Plan and Action Plan for the Prevention and Control of
Non-Communicable Diseases in Tanzania 2016–2020. Dar es Salaam: The
Government of the United Republic of Tanzania, May 2016.
18. Kalage R, Blomstedt Y, Preet R,
et al.
The INTREC Tanzania Country Report.
Dar es Salaam: Licensed under a Creative Commons Attribution 3.0 Unported
License, 2012.
19. Ministry of Health and Social Welfare & National Institute for Medical
Research. Tanzania STEPS Survey Report in collaboration with the World
Health Organisation. Dar es Salaam: MOH & NIMR, 2013.
20. Tanzania NCD Alliance (TANCDA). NCD Alliance. Tanzania civil society
catalyses national NCD programme. [Online] 2 December, 2019. https://
ncdalliance.org/news-events/news/tanzania-civil-society-catalyses-national-ncd-programme.
21. Ngalesoni F, Ruhago G, Mayige M,
et al.
Cost-effectiveness analysis of
population-based tobacco control strategies in the prevention of cardiovascular
diseases in Tanzania.
PLoS One
2017;
12
(8): e0182113.
22. Mori AT, Kaale EA, Ngalesoni F,
et al.
The role of evidence in the decision-
making process of selecting essential medicines in developing countries: the
case of Tanzania.
PLoS One
2014;
9
(1): e84824.
23. The United Republic of Tanzania. The Tobacco Products (regulation) Act,
2003. The Gazette. 2003.
24. Kidane A, Mduma J, Naho A,
et al.
Advances in the demand for cigarettes
in Tanzania and implications for tobacco taxation policy.
Advances Econom
Business
2015;
3
(10): 428–435.
25. Bird RM, Wallace S. Taxing alcohol in Africa: reflections and updates.
International Studies Program Working Paper 10–31 October 2010.
26. TANCDA. Tanzania Non-communicable Diseases Alliance (TANCDA).
TANCDA constituents organizations. [Online] 2018. Available: https://www.
tancda.or.tz.
27. The East African NCDAlliance. A civil society benchmark report – responses
to NCDs in East Africa: The East Africa NCD Alliance Initiative. Geneva,
Switzerland: East Africa NCD Alliance Civil Society Survey Report, June
2014.
28. Michaela D, Kezakubia D, Juma A,
et al.
The feasibility and acceptability
of screening for hypertension in private drug retail outlets: a pilot study in
Mwanza region, Tanzania.
Int Health
2016;
8
: 360–369.
29. Kolumbia L. Tanzania called upon to enact strong anti-tobacco laws.
The
Citizen
[Online] Friday May 31 2019.
https://www.thecitizen.co.tz› News.
30. World Health Organization. Global Health Observatory May 2017.
[Online] 2018. Available:
http://apps.who.int/gho/data/node.cco; ccsbrief_
tza_en.pdf.